VOLUME 68   2007   NUMBER 8

Original Articles

1163 Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder. Eduardo Dunayevich, Haya Ascher-Svanum, Fangyi Zhao, Jennie G. Jacobson, Glenn A. Phillips, Mary Anne Dellva, and Alan I. Green
[Abstract] [PDF]

1172 Adherence to Pharmacotherapy in Bipolar Disorder Patients With and Without Co-Occurring Substance Use Disorders. Sumita G. Manwani, Kathleen A. Szilagyi, Benjamin Zablotsky, John Hennen, Margaret L. Griffin, and Roger D. Weiss
[Abstract] [PDF]

1177 Lithium Augmentation Compared With Phenelzine in Treatment-Resistant Depression in the Elderly: An Open, Randomized, Controlled Trial. Rob M. Kok, Dagmar Vink, Thea J. Heeren, and Willem A. Nolen
[Abstract] [PDF]

1186 Cognitive Functioning and Acute Sedative Effects of Risperidone and Quetiapine in Patients With Stable Bipolar I Disorder: A Randomized, Double-Blind, Crossover Study. Philip D. Harvey, Howard Hassman, Lian Mao, Georges M. Gharabawi, Ramy A. Mahmoud, and Luella M. Engelhart
[Abstract] [PDF]

1195 Is There a Common Resilience Mechanism Underlying Antidepressant Drug Response? Evidence From 2848 Patients. Hans H. Stassen, Jules Angst, Daniel Hell, Christian Scharfetter, and Armin Szegedi
[Abstract] [PDF]

1206 Differential Prediction of First Clinical Response to Serotonergic and Noradrenergic Antidepressants Using the Loudness Dependence of Auditory Evoked Potentials in Patients With Major Depressive Disorder. Georg Juckel, Oliver Pogarell, Holger Augustin, Christoph Mulert, Florian Müller-Siecheneder, Thomas Frodl, Paraskevi Mavrogiorgou, and Ulrich Hegerl
[Abstract] [PDF]

1213 A Systematic Review of Placebo Response in Studies of Bipolar Mania. Robyn Sysko and B. Timothy Walsh
[Abstract] [PDF]

1218 Equivalent Switching Dose From Oral Risperidone to Risperidone Long-Acting Injection: A 48-Week Randomized, Prospective, Single-Blind Pharmacokinetic Study. Ya Mei Bai, Tzu Ting Chen, Jen-Yeu Chen, Wen-Ho Chang, Bojian Wu, Chih Hung Hung, and Wen Kuo Lin
[Abstract] [PDF]

1226 Combination Therapy of Zonisamide and Bupropion for Weight Reduction in Obese Women: A Preliminary, Randomized, Open-Label Study. Kishore M. Gadde, Gretchen M. Yonish, Mariko S. Foust, and H. Ryan Wagner II
[Abstract] [PDF]

1230 Pramipexole in Psychiatry: A Systematic Review of the Literature. Chris B. Aiken
[Abstract] [PDF]

1237 Mood Symptoms, Functional Impairment, and Disability in People With Bipolar Disorder: Specific Effects of Mania and Depression. [CME] Gregory E. Simon, Mark S. Bauer, Evette J. Ludman, Belinda H. Operskalski, and Jürgen Unützer
[Abstract] [PDF]

1246 The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases. Martin B. Keller, Madhukar H. Trivedi, Michael E. Thase, Richard C. Shelton, Susan G. Kornstein, Charles B. Nemeroff, Edward S. Friedman, Alan J. Gelenberg, James H. Kocsis, David L. Dunner, Robert M. A. Hirschfeld, Anthony J. Rothschild, James M. Ferguson, Alan F. Schatzberg, John M. Zajecka, Ronald D. Pedersen, Bing Yan, Saeeduddin Ahmed, Jeff Musgnung, and Philip T. Ninan
[Abstract] [PDF]

1257 Sleep Disturbance in Adults With Posttraumatic Stress Disorder: A Review. [CME] Lynne J. Lamarche and Joseph De Koninck
[Abstract] [PDF]

1271 How Often Do SSRIs and Other New-Generation Antidepressants Lose Their Effect During Continuation Treatment? Evidence Suggesting the Rate of True Tachyphylaxis During Continuation Treatment Is Low. Mark Zimmerman and Tavi Thongy
[Abstract] [PDF]

Focus on Women's Mental Health

1277 New Data Inform the Risk/Benefit Analysis in Antenatal Depression. Marlene P. Freeman
[PDF]

1279 Sudden Infant Death Syndrome and Maternal Depression. Louise M. Howard, Graham Kirkwood, and Radoslav Latinovic
[Abstract] [PDF]

1284 Birth Outcomes Following Prenatal Exposure to Antidepressants. Kimberly H. Pearson, Ruta M. Nonacs, Adele C. Viguera, Vicki L. Heller, Laura F. Petrillo, Mina Brandes, John Hennen, and Lee S. Cohen
[Abstract] [PDF]

Academic Highlights

1290 Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy, Part 2: Focus on Maintenance. [CME]
[PDF]

ASCP Corner

1301 Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 1: Challenges and Developments. Christoph U. Correll
[PDF]

A Psychiatrist's Diary

1303 My First Day. Shyam K. Bhat
[PDF]

Letters To the Editor

1305 Intranasal Ketamine for Intermittent Explosive Disorder: A Case Report. Jon E. Berner
[PDF]

1305 Cognitive Facilitation and Behavioral Disinhibition With Benzodiazepine: A Case Report. Raphaël Gaillard, Amal Hemras, Marie-Odile Habert, Nicolas Baup, Lionel Naccache, Thierry Gallarda, Laurent Cohen, and Jean-Pierre Olié
[PDF]

1307 Applicability of the Oral Glucose Tolerance Test in Assessing Prevalence and Incidence of Diabetes Mellitus in Schizophrenia. Dan Cohen
[PDF]

  • Reply by Ruud van Winkel and Marc De Hert

1309 Prolonged QT Associated With an Overdose of Trazodone. Philip B. Dattilo and Charles Nordin
[PDF]

1310 Clozapine Interchangeability Issues. Sean Willam Flynn
[PDF]

  • Reply by Silvia Alessi-Severini

Book Reviews 1312

Electronic CME Activity

Available through www.psychiatrist.com/toc

e20 Impact of Substance Use Disorder on ADHD and Its Treatment. Timothy E. Wilens and Himanshu P. Upadhyaya